
TB Throwback: Dr. Avindra Nath and HERV-based Diseases
From Talking Biotech with Dr. Kevin Folta by Colabra
December 13, 2025 · 51 min · Episode 483
About this episode
Dr. Avindra Nath discusses the impact of human endogenous retroviruses on human diseases.
In today's throwback to 2022, Dr. Avindra Nath of the NIH reviews research efforts in proteins expressed from human endogenous retroviruses. It is a fascinating discussion of how genome relics may be contributing to insidious human disease.
People in this episode
Guest: Dr Avindra Nath
Topics covered
- human endogenous retroviruses
- disease
- genome relics
Keywords
- NIH
- proteins
- research
More episodes of Talking Biotech with Dr. Kevin Folta
- Milk Proteins without the Dairy - Adam Tarshis and Dr. Cory Tobin · June 9, 2026 · 48 min
- New Technology in Severe Burn Care - Dr. Katie Bush · June 1, 2026 · 29 min
- Molecular Residue Cancer Detection - Dr. Nate Montgomery · May 25, 2026 · 37 min
- Strategies in Combating Chronic Kidney Disease - Dr. Salvatore Viscomi · May 17, 2026 · 38 min
- AI and the Future of Healthcare -- Dr. Emilia Javorsky · May 8, 2026 · 39 min
- The First Environmental GE Organism Release - almost! Dr. Steven Lindow · April 28, 2026 · 26 min
Explore listener stats, chart rankings, contacts and more on the Talking Biotech with Dr. Kevin Folta podcast page.